PM: decision on the application for modification of an agreed PIP
Decision date
Decision
P/0012/2020: EMA decision of 6 January 2020 on the acceptance of a modification of an agreed paediatric investigation plan for tezepelumab (EMEA-001613-PIP01-14-M04)
Public summary of the evaluation of a proposed paediatric investigation plan: Human immunoglobulin G2Lambda monoclonal antibody directed against thymic stromal lymphopoietin (MEDI9929) for the treatment of asthma